KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma

by Cai, J.-B, Chai, X.-Q, Fan, J., Gao, C., Guo, X.-J, Huang, X.-Y, Ke, A.-W, Li, Y.-C, Lu, J.-C, Shi, G.-M, Wang, S.-W, Zhang, P.-F, Zheng, Y.-M
Published 2022